Lv51
968 积分 2021-10-22 加入
Sequential treatment with PARPi and WEE1i enhances antitumor immune responses in preclinical models of ovarian cancer
3小时前
已完结
CAR T-cell Efficacy in Solid Tumors Is Enhanced by Oncolytic Viruses
2个月前
已完结
Update on Adipose Tissue and Cancer
3个月前
已完结
中国卵巢癌规范诊疗质量控制指标(2022版)
3个月前
已完结
Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity
6个月前
已完结
Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring HRR Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial
8个月前
已完结
Homologous Recombination Deficiency in Ovarian Cancer: from the Biological Rationale to Current Diagnostic Approaches
9个月前
已关闭
Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall Survival
9个月前
已关闭
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis
9个月前
已完结
Dendritic cells as shepherds of T cell immunity in cancer
1年前
已完结
皖公网安备34019202002308
